Paige is the builder of computational pathology products created to help patients and doctors perform more informed medical diagnostics. This company was founded by Thomas Fuchs, David Klimstra, Norman Selby and Peter Schüffler in 2017 and is headquartered in New York, NY. Paige.ai also helps life sciences companies evaluate and design personalized treatments for patients thanks to their use of machine learning and technology.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/02/2023 | Series C-1 | $19.5MM | $xx.xx | $656.14MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
757,710
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
03/10/2021 | Series C | $125.36MM | $xx.xx | $605.33MM | KKR, Casdin Capital, Johnson & Johnson, Catalio Capital Management | |
Price per Share
$xx.xx
Shares Outstanding
4,871,125
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
KKR, Casdin Capital, Johnson & Johnson, Catalio Capital Management
|
||||||
07/13/2020 | Series B | $71.04MM | $xx.xx | $226.79MM | Goldman Sachs, Healthcare Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
5,186,838
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Goldman Sachs, Healthcare Venture Partners
|
||||||
04/23/2020 | Series A-1 | $6MM | $xx.xx | $52.33MM | Goldman Sachs | |
Price per Share
$xx.xx
Shares Outstanding
1,223,684
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Goldman Sachs
|
||||||
02/05/2018 | Series A | $25.4MM | $xx.xx | $46.18MM | Breyer Capital | |
Price per Share
$xx.xx
Shares Outstanding
5,180,260
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Breyer Capital
|